| 摘要 |
PURPOSE: Provided is an anticancer agent which comprises sodium butyrate as an active ingredient and pharmaceutically acceptable carrier, inhibits angiogenesis-promoting factor and is used as a therapeutic for angiogenesis related solid cancer. CONSTITUTION: The anticancer agent is characterized by comprising sodium butyrate as an active ingredient, and pharmaceutically acceptable carrier. It specifically inhibits angiogenesis-promoting factor and vasculogenesis, and is thus as a therapeutic for angiogenesis related solid cancer.
|
